Background: Clostridial bacteremia (CB) is the second most frequent anaerobic bacteremia, and CB patients show high mortality without prompt antimicrobial therapy. We retrospectively reviewed 11 years of CB cases in a tertiary care hospital to describe the clinical and microbiological characteristics of CB and to define the risk factors of fatal CB. Methods: All patients with CB from January 2002 to December 2012 were included in the study. Age, sex, underlying diseases, antibiotic use, and clinical outcome were reviewed. Antibiotic therapy was classified as either 'appropriate' or 'inappropriate' based on the activity against Clostridium species. Results: A total of 118 Clostridium isolates (0.79% of all blood culture isolates) were recovered from the blood cultures of 114 patients. The underlying conditions of patients with CB were neoplasm in 87 cases (76.3%), gastrointestinal symptoms in 84 cases (73.7%), diabetes in 17 cases (14.9%), and hemodialysis in six cases (5.3%). Of the 118 Clostridium isolates, C. perfringens was the most frequent species (42 isolates, 35.6%). Thirty-two patients (28.1%) showed polymicrobial bacteremia, which was most commonly combined with Escherichia coli. Two patients harbored more than two Clostridium species. 'Appropriate' antibiotics were given to 97 (85.1%) patients. The mortality rate of CB at days 2, 8, and 30 was 7.9% (9/114), 14.0% (16/114), and 26.3% (30/114), respectively. Conclusion: Neoplasm, especially in the gastrointestinal tract or of hematologic origin, and hemodialysis were considered to be risk factors of blood stream clostridial infection. Early appropriate antibiotic coverage of CB was not definitely associated with lower mortality in our study. 
INTRODUCTION
Anaerobic bacteremia is uncommon. The frequency of anaerobic bacterial isolation in hospitals accounts for 0.5-9% of all positive blood cultures [1] . Clostridium is a genus of anaerobic, Gram-positive, spore-forming bacteria and is a clinically important pathogen causing anaerobic infections in humans [2] .
Clostridium species account for the second most frequent number of anaerobes isolated from blood, with Clostridium perfringens the most common species [2, 3] .
Among hospitalized patients, clostridial bacteremia (CB) represents less than 2% of positive blood cultures and is predominantly found as part of polymicrobial bacteremia cases [4] . CB patients show high mortality [5] and the disease is usually rapidly fatal without prompt and appropriate antimicrobial therapy [6, 7] . However, treatment may not always be required when Clostridium species are isolated from blood cultures, as the detection of clostridial species may be transient or may even be due to specimen contamination [8] . In one study, the clinical relevance of Clostridium isolation from blood cultures was doubtful in one-third of the cases, but in two-thirds of the cases, clostridial isolation were considered to be of clinical significance [9] .
CB has a primary association with intra-abdominal sepsis af-
Definitions

1) Community-acquired infection:
Blood cultures were obtained within 48 h of admission, the patient had not been discharged from a hospital within the preceding week, and the bacteremia was not related to a procedure performed in the hospital [9] .
2) Healthcare-associated infection: When the first sign of infection appeared ＞48 h following admission, or the infection was related to an in-hospital procedure even within the first 48 h of admission, or the patient had been hospitalized within the previous week [9] .
3) Polymicrobial infection: One or more additional bacterial species isolated from blood concurrently with Clostridium species.
RESULTS
The 114 patients who had at least one positive blood culture episode for Clostridium species were reviewed. A total 118
Clostridium isolates were found from these patients. Identification of the same isolates from the same patient within one month was considered a single isolate. Of all positive blood cultures during the 11-years study period at our hospital, Clostridium species were found in 0.79% (118/14,905) of all blood culture isolates.
Of the 118 Clostridium isolates, C. perfringens was the most frequent species (42 isolates, 35.6%), followed by C. clostridioforme (20, 16.9%), Clostridium species-not-definitely identified (14, 11.9%), C. bifermentans (10, 8 .5%), C. histolyticum (7, 5 .9%), C. difficile (6, 5.1%), and C. septicum (5, 4.2%). The details are described in Table 1 and Fig. 1 Clostridium bifermentans (10)
Clostridium histolyticum ( Percentages were described in Clostridium species with more than 5 cases. *Clostridium species: Clostridium species that were not definitely identified to the species level. Abbreviations: DM, diabetes mellitus; GI, gastrointestinal; HD, hemodialysis. 'Appropriate' antibiotics were given to 97 patients (85.1%), but 'inappropriate' antibiotics were administered to 14 patients (12.3%), and no antibiotics were given to three patients (2.6%).
Of the patients who received 'appropriate' antibiotics, the most commonly used antimicrobial agents were carbapenem with or without cilastatin, piperacillin-tazobactam, metronidazole, and clindamycin.
However, the mortality rates were not significantly different between patients receiving 'appropriate' antibiotic therapy and those receiving 'inappropriate' antibiotics for CB: 8.2% and 14.4% of 2-day and 8-day mortality rates in patients receiving 'appropriate' therapy and 7.1% and 14.3% of 2-day and 8-day mortality rates in those receiving 'inappropriate' antibiotics (P= 0.89 and 0.99, respectively). In 87 patients with neoplasms, the mortality rates of 76 patients receiving 'appropriate' antibiotics were 9.2% at day 2 and 15.8% at day 8, while the mortality rates of 11 patients on 'inappropriate' antibiotics were 9.1% at day 2 and 18.2% at day 8 (P=0.99 and 0.84, respectively). Of the 27 patients without neoplasms, the mortality rate was 4.8%
(one subject) at day 2 and 9.5% (two subjects, accumulated) at day 8 in 21 patients that received 'appropriate' antibiotics, while in the 'inappropriate' group, no subject expired at day 2 nor day 8 (P=0.70 and 0.58, respectively).
DISCUSSION
Clostridium species have been found occasionally in polymicrobial bacteremia. In this study, 28.1% (32/114) of CB patients had polymicrobial bacteremia. Other studies have reported variable rates of polymicrobial bacteremia in CB patients, ranging from 8% to 39% [6, 7, 12, 15] . Clostridium species that were the most associated with polymicrobial bacteremia in ratio included C. difficile (50%, 3/6) as the major Clostridium species (recovered in more than five cases) followed by C. perfringens (38.1%, 16/42). Among the minor clostridial species (less than five cases), C. tertium, C. paraputrificum, and C. baratii seemed to be closely associated with polymicrobial bacteremia (Table   1 ).
In our study, the most common medical conditions in patients with CB were neoplasms (87/114, 76.3%), and the proportion of the patients with neoplasm in CB was significantly higher than those in non-CB ( Table 2 ). The most common type of neoplasm was gastrointestinal malignancy (60/87, 69.0%), and the second most common type was hematologic malignancy (14/87, 16.1%).
In previous reports, the most commonly related malignancies were gastrointestinal, genitourinary and hematologic malignancies [4, 7, 10, 12, 16] . Our results are consistent with previous reports, although the ethnic group is limited to the Korean population in our study. Other known underlying conditions included diabetes mellitus and hemodialysis [4, 7, 10, 12, 16] . In our study, healthcare-associated CB accounts for 47%
(55/118) of CB cases, which is higher than 31% that were reported in a previous report [9] . Healthcare-associated bacteremia was most frequently found with C. bifermentans (70%, 7/10).
More than 50% was related with healthcare-associated bacteremia in C. histolyticum (57.1%, 4/7) and C. difficile (50%, 3/6) in major clostridial species. In minor species, C. baratii, C.
sporogenes, C. hastiforme, C. subterminale, C. tertium, and C. paraputrificum seemed to be related to healthcare-associated infection ( Table 1 ).
The mortality rate of CB at days 2, 8, and 30 was 7.9%, 14.0%, and 26.3%, respectively, which is lower than 32% at day 2 and 59% at day 28 that were reported in a previous report [12] . Although it is controversial whether early antibiotic therapy for CB could decrease the mortality rate or not [5, 12, 15, 17] , it seems that the difference of appropriate antibiotic coverage rate in early phase of bacteremia between the previous study (64%) [12] and our study (85.1%) might be related with the difference of the mortality rate. But, direct comparison is not justi- 
